171 related articles for article (PubMed ID: 1740491)
21. Inhibition of gonadotropin surge by a brief mid-cycle regimen of ethinyl estradiol and norethindrone: possible role in in vitro fertilization.
Letterie GS
Gynecol Endocrinol; 2000 Feb; 14(1):1-4. PubMed ID: 10813099
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[TBL] [Abstract][Full Text] [Related]
23. Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration.
Danforth DR; Dubois C; Ulmann A; Baulieu EE; Hodgen GD
Contraception; 1989 Aug; 40(2):195-200. PubMed ID: 2503298
[TBL] [Abstract][Full Text] [Related]
24. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
25. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
[TBL] [Abstract][Full Text] [Related]
26. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
[TBL] [Abstract][Full Text] [Related]
27. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
[TBL] [Abstract][Full Text] [Related]
28. The dynamic interaction between steroids and gonadotropins in the mammalian ovulatory cycle.
Mahesh VB
Neurosci Biobehav Rev; 1985; 9(2):245-60. PubMed ID: 3925394
[TBL] [Abstract][Full Text] [Related]
29. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
30. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
[TBL] [Abstract][Full Text] [Related]
31. Low-dose follicular-phase cocaine administration disrupts menstrual and ovarian cyclicity in rhesus monkeys.
Potter DA; Luther MF; Eddy CA; Siler-Khodr TM; King TS; Schenken RS
J Soc Gynecol Investig; 1999; 6(2):88-94. PubMed ID: 10205779
[TBL] [Abstract][Full Text] [Related]
32. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
33. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
34. Roles of estradiol and progesterone in eiliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges.
March CM; Goebelsmann U; Nakamura RM; Mishell DR
J Clin Endocrinol Metab; 1979 Oct; 49(4):507-13. PubMed ID: 479343
[TBL] [Abstract][Full Text] [Related]
35. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model.
Martin KA; Welt CK; Taylor AE; Smith JA; Crowley WF; Hall JE
Neuroendocrinology; 1998 Jun; 67(6):363-9. PubMed ID: 9662715
[TBL] [Abstract][Full Text] [Related]
36. Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 days.
Baird DT; Thong KJ; Hall C; Cameron ST
Hum Reprod; 1995 Sep; 10(9):2270-6. PubMed ID: 8530650
[TBL] [Abstract][Full Text] [Related]
37. Hormonal evaluation and midcycle detection of intrauterine glycodelin in women treated with levonorgestrel as in emergency contraception.
Durand M; Koistinen R; Chirinos M; Rodríguez JL; Zambrano E; Seppälä M; Larrea F
Contraception; 2010 Dec; 82(6):526-33. PubMed ID: 21074015
[TBL] [Abstract][Full Text] [Related]
38. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
39. The functional changes of the pituitary gonadotrophs during the menstrual cycle.
Wang CF; Lasley BL; Lein A; Yen SS
J Clin Endocrinol Metab; 1976 Apr; 42(4):718-28. PubMed ID: 770496
[TBL] [Abstract][Full Text] [Related]
40. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
